This valuation method assumes that the stock valuation will revert to its historical (10-Year) median in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
STU:LSI'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.48 Med: 0.92 Max: 1.24
Current: 0.83
During the past 13 years, the highest Price to Median PS Value of CK Life Sciences International Holdings was 1.24. The lowest was 0.48. And the median was 0.92.
STU:LSI's Price-to-Median-PS-Value is ranked worse than 65.94% of 276
companies
in the Biotechnology industry
Industry Median: 0.63
vs STU:LSI: 0.83
CK Life Sciences International Holdings (STU:LSI) Median PS Value Explanation
This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio
is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.
It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.
CK Life Sciences International Holdings's Price to Median PS Value for today is calculated as
Price to Median PS Value
=
Share Price
/
Median PS Value
=
0.066
/
0.08
=
0.83
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Median PS Value Related Terms
CK Life Sciences International Holdings Median PS Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings Median PS Value Chart
CK Life Sciences International Holdings Annual Data
STU:LSI vs VRTX, REGN, ALNY: Median PS Value Comparison
For the Biotechnology subindustry, CK Life Sciences International Holdings's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
CK Life Sciences International Holdings Price-to-Median-PS-Value vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, CK Life Sciences International Holdings's Price-to-Median-PS-Value distribution charts can be found below:
* The bar in red indicates where CK Life Sciences International Holdings's Price-to-Median-PS-Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CK Life Sciences International Holdings (STU:LSI) has a Median PS Value of €0.08 as of Jun. 24, 2026. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on CK Life Sciences International Holdings and its competitors. This is 91% below median its historical median of 0.92. Over the past decade, CK Life Sciences International Holdings' Median PS Value has ranged from 0.48 to 1.24. According to the industry distribution chart, CK Life Sciences International Holdings ranks #182 out of 276 companies in the Biotechnology industry, placing it in the top 65.9%.
Is CK Life Sciences International Holdings' Median PS Value too high?
CK Life Sciences International Holdings' current Median PS Value of €0.08 is 91% below median its 10-year median of 0.92. Over the past 10 years, this metric has ranged from a low of 0.48 to a high of 1.24. Based on the distribution chart, CK Life Sciences International Holdings ranks #182 out of 276 companies in the Biotechnology industry, which is below the industry midpoint. Overall, CK Life Sciences International Holdings has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does CK Life Sciences International Holdings' Median PS Value compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, CK Life Sciences International Holdings ranks #182 out of 276 companies for Median PS Value. This places CK Life Sciences International Holdings in the lower half of its industry. The industry median Median PS Value is 0.63. Historically, CK Life Sciences International Holdings' own Median PS Value has ranged from 0.48 to 1.24 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Median PS Value for a Biotechnology company?
The median Median PS Value among Biotechnology companies is 0.63, based on 276 companies in the industry. Companies in the top quartile (top 25%) have a Median PS Value significantly above this median, while those in the bottom quartile fall well below. However, Median PS Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Median PS Value mean?
A high Median PS Value can signal that a stock is expensive relative to its fundamentals. Median price-sales value is the stock value based on a company's 10-year median price-sales ratio, View historical data on CK Life Sciences International Holdings and its competitors. For the Biotechnology industry, the median Median PS Value is 0.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CK Life Sciences International Holdings's current Median PS Value is €0.08, which is 91% below median its own 10-year median of 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CK Life Sciences International Holdings stock overvalued right now?
CK Life Sciences International Holdings (STU:LSI) has a current Median PS Value of €0.08. The stock's GF Value™ is €0.08, compared to a current price of €0.07 — trading 17.5% below its estimated fair value. The current Median PS Value is €0.08, which is 91% below median its 10-year median of 0.92. CK Life Sciences International Holdings' overall GF Score™ is 34/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Median PS Value calculated?
Median PS Value is calculated from a company's financial statements. For CK Life Sciences International Holdings (STU:LSI), the current Median PS Value is €0.08 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is CK Life Sciences International Holdings (STU:LSI) Overvalued in 2026?
Based on GuruFocus' analysis, CK Life Sciences International Holdings stock appears to be undervalued.
The current stock price of €0.07 is trading 17.5% below its estimated GF Value™ of €0.08.
Key valuation signals for STU:LSI:
Median PS Value: €0.08 (91% below median its 10-year median of 0.92)
GF Value™: €0.08 vs. price of €0.07 (17.5% below fair value)
No single metric tells the full story. See the STU:LSI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
CK Life Sciences International Holdings Business Description
CK Life Sciences International Holdings Inc is an international life sciences company. It is engaged in research and development, manufacturing, commercialization, marketing and selling of health and agriculture-related products, as well as investment in a portfolio of vineyards, and various financial and investment products. Its pipeline includes Seviprotimut-L, TTX-MC138, Seviprotimut-L + TTX-MC138, TTX-RIGA, Halneuron, among others. Its segments include Agriculture-related, Nutraceutical, and Pharmaceuticals & Diagnostics R&D with the majority of the revenue deriving from Nutraceutical segment. Geographically it operates in Asia Pacific that derives the majority of the revenue and North America.
34GF Score
Get the complete analysis for STU:LSI
Median PS Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:LSI has been successfully added to your 
